LIVE TV
LIVE TV
LIVE TV
Home > Business > Anlon Healthcare Share: Listing Day Letdown Or Silent Winner, Planning To Invest?

Anlon Healthcare Share: Listing Day Letdown Or Silent Winner, Planning To Invest?

Anlon Healthcare IPO shares made a slow start on its date of listing today. The share was listed at Rs.92 on NSE, over their IPO issue price of Rs.86-Rs.91 per share. Anlon Healthcare Limited is a Rajkot, Gujarat based company dealing in research-based pharma company. Should you invest after listing?

Published By: Ankur Mishra
Last updated: September 3, 2025 15:03:28 IST

Add NewsX As A Trusted Source

Anlon Healthcare IPO shares made a slow start on its date of listing today. The share was listed at Rs.92 on NSE, over their IPO issue price of Rs.86-Rs.91 per share. 

The initial public offer (IPO) was opened on Aug 26, 2025 and closed on Aug 29, 2025. The objective of the company was to raise around Rs.121 crore. The price band of the IPO was from Rs.86 – Rs.91 per share with 164 equity share in one lot. The minimum investment for retail investors was around Rs.14,104. KFin Technologies Limited was the registrar of this public issue.

Anlon Healthcare Limited IPO has been 7.13 times subscribed. The segment-wise consolidated investors participation are as follows:

  • Total Subscription: 7.13x
  • Retail Investors: 47.30x
  • Qualified Institutional Buyers (QIBs): 1.07x
  • Non-Institutional Investors (NIIs): 10.61x

(Data: August 29, 2025)

Anlon Healthcare IPO: Day 1 Share Price

  • Share Opening Price: Rs. 92
  • Share Price (Maximum): Rs. 92
  • Share Price (Minimum): Rs. 91

(Data: Sep 03, 2025 | 14:20 PM)

Anlon Healthcare IPO: Company Overview

Anlon Healthcare Limited is a Rajkot, Gujarat based company dealing in research-based pharma company. The company operates in pharmaceutical industry with a focus on manufacturing Active Pharmaceutical Ingredients (APIs) along with Pharmaceutical Intermediates, targeting local and global markets. The company’s operations are highly organized in pharmaceutical industry, with clients over 50 countries across the Americas, Europe, Africa, Middle East, and Asia.

(Disclaimer: The above article is only for the purpose of information. It does not constitute financial guidance in any form(s). Investors here are suggested to carefully review the prospectus and refer to a registered financial advisor or certified investment professional before they finalise any investment.)

Also Read: Vikran Engineering Shares On Listing Day: Was The Hype Real, Should You Invest Now?

RELATED News

LATEST NEWS